Development of a new carcinomatous pleural effusion/ascites screening laboratory procedure based on the measurement of protoporphyrins.

Development of a new carcinomatous pleural effusion/ascites screening laboratory procedure based on the measurement of protoporphyrins. - Development of new examination for carcinomatous pleural effusion and ascites

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005652

Enrollment

Registered

2011-05-30

Start date

2011-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carcinomatous pleural effusion and carcinomatous ascites

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases who have pleural effusion or ascites fluid

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
ROC curve and t test. Protoporphyrins in fluid samples are measured in carcinomatous pleural effusion, carcinomatous ascites and the control.	—

Countries

Japan

Contacts

Public ContactToshiki Yamamoto

Surugadai Nihon University Hospital Division of Gastroenterology and Hepatology, Department of Medicine

yamamoto.toshiki@nihon-u.ac.jp03-3293-1711

Outcome results